Hyperfractionated Radiation Therapy and Concurrent 5-Fluorouracil, Cisplatin and Mitomycin-C in Head and Neck Carcinoma A Pilot Study-Reference-Cited by-同舟云学术

Hyperfractionated Radiation Therapy and Concurrent 5-Fluorouracil, Cisplatin and Mitomycin-C in Head and Neck Carcinoma A Pilot Study

Published:1992-06 Issue:3 Volume:15 Page:250-255
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Abitbol Andre A.,Schwade James G.,Lewin Alan A.,Sridhar Kasi,Brandon Alfred H.,Markoe Arnold M.,Casiano Roy R.,Houdek Pavel V.,Serago Christopher,Miller Dawn J.,Hush Meryl S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventions to prevent suicidal behavior and ideation for patients with cancer: A systematic review;General Hospital Psychiatry;2019-09

2. Final results of a phase II single-institutional trial with hyperfractionated radiation therapy (HFX) and four-weekly continuous cisplatin in locally advanced head and neck carcinoma;Clinical and Translational Oncology;2013-11-08

3. Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): Long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin;Radiotherapy and Oncology;2012-08

4. Phase II Study of Tolerance and Efficacy of Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin, and Paclitaxel (Taxol) and Amifostine (Ethyol) in Head and Neck Squamous Cell Carcinomas;American Journal of Clinical Oncology;2005-10

5. Quality-of-Life Assessment After Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin, and Paclitaxel (Taxol) in Inoperable and/or Unresectable Head and Neck Squamous Cell Carcinoma;American Journal of Clinical Oncology;2005-08